Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma
about
Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokininThe Role of Gastrin and CCK Receptors in Pancreatic Cancer and other MalignanciesRole of Parathyroid Hormone-Related Protein Signaling in Chronic PancreatitisClosing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma.G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.Cholecystokinin and pancreatic cancer: the chicken or the egg?Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease?Expression of multiple forms of 3'-end variant CCK2 receptor mRNAs in human pancreatic adenocarcinomas.Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat.Acinar cell-specific knockout of the PTHrP gene decreases the proinflammatory and profibrotic responses in pancreatitis.Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in micePancreatic stellate cells produce acetylcholine and may play a role in pancreatic exocrine secretion.Autocrine and paracrine signaling through neuropeptide receptors in human cancer.Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival.PPARalpha agonist-induced rodent tumors: modes of action and human relevance.A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosisThe production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.Cancer imaging: Gene transcription-based imaging and therapeutic systems.Small Molecules for Active Targeting in Cancer.Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.Role of endogenous cholecystokinin on growth of human pancreatic cancer.Molecular characterization and organ distribution of type A and B cholecystokinin receptors in cynomolgus monkey.Sulfated Cholecystokinin-8 Promotes CD36-Mediated Fatty Acid Uptake into Primary Mouse Duodenal Enterocytes.Cholecystokinin and Somatostatin Negatively Affect Growth of the Somatostatin-RIN-14B Cells.A Speculative Role for Stromal Gastrin Signaling in Development and Dissemination of Pancreatic Ductal AdenocarcinomaCholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth.Genetic analysis of pancreatic duct hyperplasia in Otsuka Long-Evans Tokushima Fatty rats: possible association with a region on rat chromosome 14 that includes the disrupted cholecystokinin-A receptor gene.
P2860
Q24672870-E0AEF4E0-3FD1-44E8-8F5E-0BC90958B842Q26765244-48A9301F-A662-43F0-9D9A-0B5E8F6FA78BQ27023929-404BADE5-81CE-4EAC-A251-91CFF1D0723EQ30881613-7E41CF9E-8849-4DE4-98FE-2E9599C9026EQ31809911-34FD28A3-2D65-4EA8-A491-DA50F0C95429Q33816883-01347133-74CB-4626-A15A-F0D6C194CB0AQ33849781-A254A66A-AC3A-4ECC-9E46-6276490E4FE6Q33876919-4461EC28-7E5E-479A-8D37-F23E37D3ACC7Q33894658-20047274-E5BA-404D-9C20-79881F0CD853Q34131104-B33D2311-C045-4D51-A1CB-6DDBF1B20BC7Q34167464-227BDCE4-D3C3-47CA-BE9E-BD221D35E627Q34182650-3E300C57-B07C-4754-B91F-42A8502C657DQ34225976-6585CDDE-3990-4E06-BB7F-C83BA3C735FCQ35079421-62C6B613-FBED-46C9-B62E-4EEB30CB3E41Q35631058-1679B1E5-1559-4421-9BED-242D114E00A6Q35911669-F8D89E8E-8A91-4FE4-A269-4A965FF2C0A5Q36042155-E18C22AA-50C1-43B8-B946-B677CF4CE844Q37650725-83CF13EF-FE3A-4308-A67C-FD721D52C0DEQ37986315-689DF10E-145E-4AD8-9E42-D3B92495C627Q38780383-FF8CC413-7A95-455A-9780-0E92650F1197Q39187880-78BD824C-BE57-4945-80A5-9EA3EA5C8FEBQ39615471-D4003282-83E5-49E8-ABBC-0F851C1471A2Q40793515-ECE2819A-8E3D-439B-B7CC-84218D675687Q41626705-0EEFFB05-8008-4579-8C22-B88BB42AD2F3Q41774762-15AC5612-BA43-4DC5-B6DF-4E6CDF966654Q41902545-747D98BB-6720-4954-B8B3-A882BF1BDF24Q44377511-C5B717BA-77C9-4D5E-877E-EB20498C1C19Q50085980-C6A15FF5-DABA-4772-B09B-D34E7DD945F6Q51833076-4137045F-372B-4E8E-9CAF-2833434DB0E0Q52542903-301C9579-2557-4018-BD29-62E857F15308
P2860
Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cholecystokinin A and B recept ...... and pancreatic adenocarcinoma
@en
Cholecystokinin A and B recept ...... and pancreatic adenocarcinoma.
@nl
type
label
Cholecystokinin A and B recept ...... and pancreatic adenocarcinoma
@en
Cholecystokinin A and B recept ...... and pancreatic adenocarcinoma.
@nl
prefLabel
Cholecystokinin A and B recept ...... and pancreatic adenocarcinoma
@en
Cholecystokinin A and B recept ...... and pancreatic adenocarcinoma.
@nl
P2093
P2860
P921
P356
P1476
Cholecystokinin A and B recept ...... and pancreatic adenocarcinoma
@en
P2093
D S Weinberg
M T Barber
S A Waldman
S Miknyocki
P2860
P304
P356
10.1172/JCI119570
P407
P577
1997-08-01T00:00:00Z